Thermo Fisher (TMO) ebitda was $9.3B in FY2025 (+5% YoY). The tables below show the complete quarterly and annual ebitda history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual EBITDA
Fiscal Year
EBITDA
YoY
2025
$9.3B
+5%
2024
$8.9B
+6%
2023
$8.4B
-14%
2022
$9.8B
-12%
2021
$11.1B
+28%
2020
$8.7B
+61%
2019
$5.4B
+18%
2018
$4.6B
+25%
2017
$3.7B
-19%
2016
$4.5B
+7%
2015
$4.2B
-7%
2014
$4.6B
+64%
2013
$2.8B
+9%
2012
$2.5B
+16%
2011
$2.2B
+9%
2010
$2.0B
+10%
2009
$1.8B
-12%
2008
$2.1B
+17%
2007
$1.8B
Recent Quarterly EBITDA
Quarter
EBITDA
Q1 2026
$2.3B
Q4 2025
$2.7B
Q3 2025
$2.3B
Q2 2025
$2.2B
Q1 2025
$2.1B
Q4 2024
$2.4B
Q3 2024
$2.2B
Q2 2024
$2.2B
Q1 2024
$2.0B
Q4 2023
$2.2B
Q3 2023
$2.2B
Q2 2023
$2.0B
Source: TMO on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.